These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38462536)

  • 21. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges.
    Ramazani F; Chen W; van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ
    Int J Pharm; 2016 Feb; 499(1-2):358-367. PubMed ID: 26795193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
    Wang T; Xue J; Hu Q; Zhou M; Luo Y
    J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine-loaded nano/micro-carriers: Techniques, bioavailability, and applications.
    Shaddel R; Akbari-Alavijeh S; Cacciotti I; Yousefi S; Tomas M; Capanoglu E; Tarhan O; Rashidinejad A; Rezaei A; Bhia M; Jafari SM
    Crit Rev Food Sci Nutr; 2024; 64(15):4940-4965. PubMed ID: 36412258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oil.
    Miranda M; Cruz MT; Vitorino C; Cabral C
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109804. PubMed ID: 31349527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications.
    Maddiboyina B; Ramaiah ; Nakkala RK; Roy H
    Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status.
    Jaimes-Aguirre L; Gibbens-Bandala BV; Morales-Avila E; Ocampo-García BE; Seyedeh-Fatemeh M; Amirhosein A
    Curr Pharm Des; 2016; 22(19):2886-903. PubMed ID: 26898743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Encapsulation, Protection, and Oral Delivery of Bioactive Proteins and Peptides using Colloidal Systems.
    Perry SL; McClements DJ
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32150848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructured lipid carriers and their current application in targeted drug delivery.
    Jaiswal P; Gidwani B; Vyas A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):27-40. PubMed ID: 24813223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
    Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
    Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mini-Review on Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Topical Delivery of Phytochemicals for the Treatment of
    Chutoprapat R; Kopongpanich P; Chan LW
    Molecules; 2022 May; 27(11):. PubMed ID: 35684396
    [No Abstract]   [Full Text] [Related]  

  • 36. Chitosan nanoparticle based delivery systems for sustainable agriculture.
    Kashyap PL; Xiang X; Heiden P
    Int J Biol Macromol; 2015; 77():36-51. PubMed ID: 25748851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application].
    Li Y; Wu ZF; Kuang WW; Li YH; Chen BY; Yang M
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):523-530. PubMed ID: 32237509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nano-scale drug delivery systems for antiarrhythmic agents.
    Nadimi AE; Ebrahimipour SY; Afshar EG; Falahati-Pour SK; Ahmadi Z; Mohammadinejad R; Mohamadi M
    Eur J Med Chem; 2018 Sep; 157():1153-1163. PubMed ID: 30189397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introducing nano/microencapsulated bioactive ingredients for extending the shelf-life of food products.
    Hosseini H; Jafari SM
    Adv Colloid Interface Sci; 2020 Aug; 282():102210. PubMed ID: 32726708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLN, NLC, LDC: state of the art in drug and active delivery.
    Attama AA
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):178-87. PubMed ID: 21834777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.